OAM
MIRM icon

Oxford Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Oxford Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,864
Closed -$430K – 648
2025
Q3 		$430K Buy
+5,864
New +$373K 0.14% 254
2025
Q1 		– Sell
-6,587
Closed -$272K – 623
2024
Q4 		$272K Buy
+6,587
New +$274K 0.12% 277

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oxford Asset Management's MIRM Position: Q4 2025 in Review

Oxford Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 5,864 shares — an estimated $430K sold.

Oxford Asset Management first reported a position in MIRM in Q4 2024 and held it in 2 quarters. The position peaked at $430K in Q3 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Oxford Asset Management reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 5,864 Mirum Pharmaceuticals shares in Q4 2025, an estimated $430K.
  • Oxford Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Oxford Asset Management's Mirum Pharmaceuticals position peaked at $430K in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.